To include your compound in the COVID-19 Resource Center, submit it here.

An inhibitor of viral latency for imaging, treating EBV-associated cancers

DISEASE CATEGORY: Cancer

INDICATION: Nasopharyngeal cancer; lymphoma

A peptide-based compound that inhibits EBNA1, which promotes Epstein-Barr virus latency, could be used to image and treat EBV-associated

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE